Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • Ucraz
    ·2021-06-10
    Additional clinical trial have always been in the plan as long as they want full FDA approval. Fda wouldn't ask them to skip EUA unless they were confident ocugen is able to pass muster
    Reply
    Report